publication date: Aug. 2, 2019

Trials & Tribulations

Barriers to clinical trial enrollment

Part I of a two-part series

Onitilo, Adedayo A MD, PhD, MSCR

Adedayo A. Onitilo, MD, PhD, MSCR, FACP

Director,

Oncology/Hematology and Radiation

Oncology Service Line

Department chair, Oncology/Hematology, Marshfield Clinic

 

Daniel_Wall 

Daniel Wall, BSc

Research administrator,

Marshfield Clinic

 

Stephanie Engelien 

Stephanie Engelien, RN, MSN

Oncology research nurse, Marshfield Clinic

 

According to the National Cancer Institute (NCI), 1,735,350 people were newly diagnosed with cancer in 2018. Of those, 65% are expected to achieve remission from their cancer 1. While most physicians agree that clinical trials advance medical knowledge and improve treatment, estimates as low as 2 – 3% of cancer patients enter clinical trials annually 2, 3. Physician knowledge of available clinical trials at their site, training in communication skills and administering clinical trials, and time constraints during … Continue reading Barriers to clinical trial enrollment

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.